评估迷走神经刺激疗法对纤维肌痛的疗效和可接受性:一项符合PRISMA标准的系统评价和荟萃分析方案

Evaluating the efficacy and acceptability of vagus nerve stimulation for fibromyalgia: a PRISMA-compliant protocol for a systematic review and meta-analysis.

作者信息

Cai Yunhuo, Zhang Yajun, Fang Yiyan, Hu Hantong, Li Xingling, Fang Lianqiang

机构信息

Department of Rehabilitation, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.

出版信息

Front Neurol. 2024 Feb 21;15:1367295. doi: 10.3389/fneur.2024.1367295. eCollection 2024.

Abstract

BACKGROUND

Fibromyalgia has imposed substantial burdens on patients' health and well-being, yet effective therapeutic options for this condition remain limited. Recently, vagus nerve stimulation (VNS) has emerged as a promising therapy for fibromyalgia. Nonetheless, despite the increasing number of randomized clinical trials (RCTs), current evidence remains inconclusive. Therefore, this protocol of a systematic review and meta-analysis aims to synthesize the existing evidence to clarify the efficacy and acceptability of VNS for treating fibromyalgia.

METHODS

A comprehensive search for eligible RCTs will be conducted across nine bibliographic databases, namely PubMed, Cochrane Library, Embase, AMED, PsycINFO, PEDro, Chinese BioMedical Literature Database, Chinese National Knowledge Infrastructure, and Wangfang database. Data obtained from the included studies will be synthesized quantitively using RevMan 5.4.1 for meta-analyses. The methodological soundness of included RCTs will be assessed via the Cochrane's updated risk of bias tool (version 2.0). Additionally, sensitivity analyses, publication bias assessment, and subgroup analyses will be conducted as appropriate. Finally, we will utilize the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to evaluate the certainty for the body of evidence.

CONCLUSION

The findings of our study are anticipated to ascertain the efficacy and acceptability of VNS as a promising treatment option for fibromyalgia. This will not only fill current research gap but also identify potential areas for future research. The findings will provide essential guidance for evidence-based treatment decisions for fibromyalgia, benefiting both patients and clinicians.

摘要

背景

纤维肌痛给患者的健康和福祉带来了沉重负担,但针对这种疾病的有效治疗选择仍然有限。最近,迷走神经刺激(VNS)已成为一种有前景的纤维肌痛治疗方法。然而,尽管随机临床试验(RCT)的数量不断增加,但目前的证据仍然不确凿。因此,本系统评价和荟萃分析方案旨在综合现有证据,以阐明VNS治疗纤维肌痛的疗效和可接受性。

方法

将在九个文献数据库中全面检索符合条件的RCT,即PubMed、Cochrane图书馆、Embase、AMED、PsycINFO、PEDro、中国生物医学文献数据库、中国知网和万方数据库。使用RevMan 5.4.1对纳入研究获得的数据进行定量合成,以进行荟萃分析。将通过Cochrane更新的偏倚风险工具(2.0版)评估纳入RCT的方法学稳健性。此外,将酌情进行敏感性分析、发表偏倚评估和亚组分析。最后,我们将利用推荐分级、评估、制定和评价(GRADE)系统来评估证据体的确定性。

结论

我们的研究结果有望确定VNS作为纤维肌痛一种有前景的治疗选择的疗效和可接受性。这不仅将填补当前的研究空白,还将确定未来研究的潜在领域。这些结果将为纤维肌痛的循证治疗决策提供重要指导,使患者和临床医生都受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa19/10914987/2a4034511f60/fneur-15-1367295-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索